Related Experiment Videos
Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants
1Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Insights
This study evaluated exchange transfusion limits for neonatal hyperbilirubinemia in Turkey. Current guidelines should be maintained, especially for infants with positive direct Coomb's tests, due to potential neurological risks.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
- Clinical Chemistry
Background:
- Neonatal hyperbilirubinemia is a common condition requiring careful management to prevent neurotoxicity.
- Established exchange transfusion limits aim to mitigate risks associated with high bilirubin levels.
- The suitability of international guidelines for local populations requires validation.
Purpose of the Study:
- To assess the applicability of recommended exchange transfusion thresholds (428-496 mumol/l, 25-29 mg/dl) in the Turkish pediatric population.
- To evaluate long-term neurodevelopmental outcomes in children treated for indirect hyperbilirubinemia.
- To identify risk factors associated with adverse neurological outcomes.
Main Methods:
- Retrospective follow-up of 102 children (8-13 years) treated for indirect hyperbilirubinemia and 27 controls.
- Assessment included physical and neurological examinations, visual and brainstem auditory evoked potentials (BAEPs), and intelligence testing (Wechsler Scale).
- Children were stratified by maximum serum bilirubin levels and direct Coomb's test results.
Main Results:
- No significant differences in visual or BAEP latencies were observed between groups.
- Children with positive direct Coomb's tests showed significantly lower IQ scores and more neurological abnormalities (p < 0.05).
- Prolonged serum indirect bilirubin levels exceeding 342 mumol/l (20 mg/dl) were identified as a significant risk factor for neurological issues.
Conclusions:
- The existing threshold of 342 mumol/l for indirect hyperbilirubinemia should be maintained for infants with positive direct Coomb's tests in Turkey.
- Given suboptimal neonatal follow-up, current exchange transfusion limits should be adhered to for infants with negative direct Coomb's tests until superior criteria are developed.
- This study underscores the importance of considering direct Coomb's test results and bilirubin levels in managing neonatal hyperbilirubinemia to prevent long-term neurological sequelae.
Objective:
This retrospective follow-up study was performed to evaluate the suitability of the recently reported exchange transfusion limits (serum indirect bilirubin level of 428-496 mumol/1, 25-29 mg/dl) for Turkey.
Material And Methods:
The study groups totalled 102 children, 8-13 years of age, who had been born at term with birthweights greater than 3000 g and had been treated for indirect hyperbilirubinemia during their newborn period; the control group consisted of 27 children of the same age-group without indirect hyperbilirubinemia. Children were grouped according to their maximum serum and bilirubin levels and direct Coomb's test results. Physical and neurological examinations, visual and brainstem auditory evoked potentials and the Wechsler Intelligence Scale for children--Revised for Turkish Children were performed.
Results:
There was no difference between the groups with regard to mean visual and brainstem auditory evoked potential latencies. Children whose direct Coomb's tests were positive had significantly lower IQ scores and more prominent neurological abnormalities (p < 0.05). IQ scores and prominent neurological abnormalities did not differ among the other groups. Nine children had prominent neurological abnormalities associated with abnormal brainstem auditory evoked potentials. An important risk factor was the duration that the infant's serum indirect bilirubin level remained greater than 342 mumol/l (20 mg/dl).
Conclusion:
The current limit of 342 mumol/l should continue to be used for infants whose direct Coomb's tests are positive in our country. Until better criteria for exchange transfusion other than the indirect bilirubin level are established, the current limits should also still be followed for infants whose direct Coomb's tests are negative in Turkey, where regular neonatal follow-up examinations are not satisfactory.